NCT03601403

Brief Summary

Chronic obstructive pulmonary disease (COPD) is a public health problem with great morbidity. The main therapeutic strategy is inhalers. The objective of this study is to determine the efficacy of a tablet-assisted training in the use of inhalers in patients with COPD including ventilatory re-education and video recordings of the patients themselves.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
42

participants targeted

Target at P25-P50 for not_applicable chronic-obstructive-pulmonary-disease

Timeline
Completed

Started Dec 2017

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2017

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 23, 2018

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

July 4, 2018

Completed
22 days until next milestone

First Posted

Study publicly available on registry

July 26, 2018

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2019

Completed
Last Updated

December 6, 2018

Status Verified

December 1, 2018

Enrollment Period

7 months

First QC Date

July 4, 2018

Last Update Submit

December 5, 2018

Conditions

Keywords

EducationDry Powder InhalersMetered Dose InhalersPulmonary DiseaseChronic Obstructive

Outcome Measures

Primary Outcomes (1)

  • Forced expiratory volume in the first second (FEV1)

    Changes from baseline to postintervention in FEV1vas evaluated by a spirometer.

    [Time Frame: baseline, 12 months]

Secondary Outcomes (9)

  • Knowledge of the Chronic Obstructive Pulmonary Disease

    [Time Frame: Baseline, 12 months]

  • Cognitive Level

    [Time Frame: Baseline]

  • Functional independence

    [Time Frame: Baseline]

  • Anxiety-depression level

    [Time Frame: Baseline, 12 months]

  • Adhesion to inhalers

    [Time Frame: Baseline]

  • +4 more secondary outcomes

Study Arms (2)

CONTROL GROUP

NO INTERVENTION

Received the standard medical and pharmacological care provided by the hospital

Inhaler technique

EXPERIMENTAL

The intervention group received the standard medical and pharmacological care provided by the hospital. In addition, a tablet-assisted training on the use of inhalers, which included an explanation of the use of inhalers together with a ventilatory re-education program.

Device: inhaler technique

Interventions

The first day of the intervention consisted primarily of ventilatory re-education. During the realization of the technique, he was videotaped with a Tablet so that later the patient could be seen and on the video to be able to give him the guidelines for the correction. On the second and third day of the intervention, ventilation re-education was performed and the inhalation technique was subsequently trained.

Inhaler technique

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed of exacerbation of COPD.
  • To possess pharmacological treatment in the form of inhalers.

You may not qualify if:

  • Inability to provide informed consent.
  • Presence of psychiatric or cognitive disorders.
  • Organ failure or cancer.
  • Inability to cooperate.
  • Patients who had experienced an exacerbation in the last month.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Health Sciences. University of Granada.

Granada, Granada, 18071, Spain

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveLung Diseases

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • M. Carmen Valenza, PH MD

    Department of Physical Therapy. University of Granada.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

July 4, 2018

First Posted

July 26, 2018

Study Start

December 1, 2017

Primary Completion

June 23, 2018

Study Completion

April 1, 2019

Last Updated

December 6, 2018

Record last verified: 2018-12

Locations